Prospects for combined use of oncolytic viruses and CAR T-cells. (2017)
Attributed to:
King's Health Partners Confidence in Concept
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s40425-017-0294-6
PubMed Identifier: 29157300
Publication URI: http://europepmc.org/abstract/MED/29157300
Type: Journal Article/Review
Volume: 5
Parent Publication: Journal for immunotherapy of cancer
Issue: 1
ISSN: 2051-1426